Startpagina>Klinisch wetenschappelijk onderzoek>Klinische studies>Treratwolfram

How to use the speech recognition tool?

2017-001215-37

Treratwolfram

A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome

Type: Interventional



Status of the trial: Active, Recruiting

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2020-10-15
  • Closing Date: 2021-08-31

Criteria

More information

Children: Yes

Adults: Yes

Funder Type: public


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Neuro-Ophthalmology Rare Diseases (WG2)

Subscribe to our mailing list

* indicates required

This ERN is supported by: